Healthcare provider profile · identity verified

Thomas Daniel Shirley

Nurse Practitioner · SEYMOUR, TN · NPI 1609218569

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Levothyroxine Sodium	Levothyroxine Sodium	367	92
Lisinopril	Lisinopril	228	66
Atorvastatin Calcium	Atorvastatin Calcium	224	62
Gabapentin	Gabapentin	224	50
Simvastatin	Simvastatin	189	53
Losartan Potassium	Losartan Potassium	187	62
Amlodipine Besylate	Amlodipine Besylate	185	59
Omeprazole	Omeprazole	176	50
Prednisone	Prednisone	161	116
Metformin Hcl	Metformin Hcl	155	47
Meloxicam	Meloxicam	138	45
Baclofen	Baclofen	115	48
Alprazolam	Alprazolam	111	25
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	107	90
Doxycycline Hyclate	Doxycycline Hyclate	101	89
Pantoprazole Sodium	Pantoprazole Sodium	94	31
Furosemide	Furosemide	85	32
Potassium Chloride	Potassium Chloride	84	29
Rosuvastatin Calcium	Rosuvastatin Calcium	84	29
Tamsulosin Hcl	Tamsulosin Hcl	82	25
Hydrochlorothiazide	Hydrochlorothiazide	81	25
Metoprolol Tartrate	Metoprolol Tartrate	81	25
Zolpidem Tartrate	Zolpidem Tartrate	81	suppressed
Eliquis	Apixaban	78	15
Albuterol Sulfate Hfa	Albuterol Sulfate	75	39
Pregabalin	Pregabalin	69	13
Pravastatin Sodium	Pravastatin Sodium	68	19
Metoprolol Succinate	Metoprolol Succinate	67	23
Citalopram Hbr	Citalopram Hydrobromide	61	17
Sertraline Hcl	Sertraline Hcl	59	17
Carvedilol	Carvedilol	57	19
Fluconazole	Fluconazole	54	40
Glipizide Er	Glipizide	53	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	52	18
Escitalopram Oxalate	Escitalopram Oxalate	50	16
Montelukast Sodium	Montelukast Sodium	48	15
Clopidogrel	Clopidogrel Bisulfate	46	16
Diclofenac Sodium	Diclofenac Sodium	46	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	46	suppressed
Fluticasone Propionate	Fluticasone Propionate	45	23
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	42	12
Metformin Hcl Er	Metformin Hcl	42	suppressed
Trazodone Hcl	Trazodone Hcl	41	16
Glimepiride	Glimepiride	40	12
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	39	12
Benazepril Hcl	Benazepril Hcl	38	suppressed
Ibuprofen	Ibuprofen	38	21
Mupirocin	Mupirocin	38	33
Alendronate Sodium	Alendronate Sodium	37	13
Clindamycin Hcl	Clindamycin Hcl	36	30
Donepezil Hcl	Donepezil Hcl	35	12
Hydralazine Hcl	Hydralazine Hcl	35	11
Duloxetine Hcl	Duloxetine Hcl	34	suppressed
Farxiga	Dapagliflozin Propanediol	34	suppressed
Mounjaro	Tirzepatide	33	suppressed
Fenofibrate	Fenofibrate	32	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	32	26
Paroxetine Hcl	Paroxetine Hcl	31	suppressed
Atenolol	Atenolol	29	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	28	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	28	suppressed
Azelastine Hcl	Azelastine Hcl	27	15
Hydroxyzine Hcl	Hydroxyzine Hcl	27	14
Meclizine Hcl	Meclizine Hcl	27	15
Tramadol Hcl	Tramadol Hcl	27	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	25	suppressed
Glipizide	Glipizide	25	12
Clonazepam	Clonazepam	24	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	24	20
Celecoxib	Celecoxib	23	suppressed
Lorazepam	Lorazepam	23	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	23	18
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	23	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	22	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	21	11
Lovastatin	Lovastatin	21	suppressed
Clonidine Hcl	Clonidine Hcl	20	12
Synthroid	Levothyroxine Sodium	20	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	19	suppressed
Cephalexin	Cephalexin	18	11
Famotidine	Famotidine	18	suppressed
Ketoconazole	Ketoconazole	18	suppressed
Jardiance	Empagliflozin	17	suppressed
Nabumetone	Nabumetone	17	suppressed
Betamethasone Dipropionate	Betamethasone Dipropionate	16	suppressed
Dropsafe Prep Pads	Alcohol Antiseptic Pads	16	suppressed
Finasteride	Finasteride	16	suppressed
Levofloxacin	Levofloxacin	16	15
Sildenafil Citrate	Sildenafil Citrate	16	suppressed
Allopurinol	Allopurinol	15	suppressed
Bisoprolol-Hydrochlorothiazide	Bisoprolol/Hydrochlorothiazide	15	suppressed
Diphenoxylate-Atropine	Diphenoxylate Hcl/Atropine	15	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	15	suppressed
Guanfacine Hcl Er	Guanfacine Hcl	15	suppressed
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	15	12
Bumetanide	Bumetanide	14	suppressed
Chlorthalidone	Chlorthalidone	14	suppressed
Mirtazapine	Mirtazapine	14	suppressed
Ramipril	Ramipril	14	suppressed
Verapamil Er	Verapamil Hcl	14	suppressed
Wixela Inhub	Fluticasone Propion/Salmeterol	14	suppressed
Buspirone Hcl	Buspirone Hcl	13	suppressed
Cefdinir	Cefdinir	13	11
Doxazosin Mesylate	Doxazosin Mesylate	13	suppressed
Memantine Hcl	Memantine Hcl	13	suppressed
Ondansetron Hcl	Ondansetron Hcl	13	11
Xarelto	Rivaroxaban	13	suppressed
Aciphex	Rabeprazole Sodium	12	suppressed
Estradiol	Estradiol	12	suppressed
Nexium	Esomeprazole Magnesium	12	suppressed
Ozempic	Semaglutide	12	suppressed
Paxlovid	Nirmatrelvir/Ritonavir	12	12
Spironolactone	Spironolactone	12	suppressed
Valsartan	Valsartan	12	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	11	suppressed
Azithromycin	Azithromycin	11	11
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	11	suppressed
Ibu	Ibuprofen	11	suppressed
Methocarbamol	Methocarbamol	11	suppressed
Methylphenidate Hcl	Methylphenidate Hcl	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error